Exelixis’ and Daiichi Sankyo’s Novel Antihypertensive Drug Minnebro® Hits the Japanese Market

Exelixis and Daiichi Sankyo launched their novel anitihypertension product Minnebro® in Japan
Exelixis (EXELand Daiichi Sankyo (This content is for paid subscribers.

Please click here to subscribe or here to log in.